Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Carl H. June

14 ta ish

University of Pennsylvania

AkademScholarda batafsil koʻrsatkichlar

  1. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

    Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner +32

    Maqola20187 iqtibos
    ABI

  2. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

    Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai +18

    MaqolaOchiq kirish20174 iqtibos
    ABI

  3. Delivery technologies for cancer immunotherapy

    Rachel Riley, Carl H. June, Róbert Langer +1

    Sharh maqolaOchiq kirish20194 iqtibos
    ABI

  4. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

    Stephan A. Grupp, Michael Kalos, David M. Barrett +10

    MaqolaOchiq kirish20133 iqtibos
    ABI

  5. CRISPR-engineered T cells in patients with refractory cancer

    Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis +38

    MaqolaOchiq kirish20203 iqtibos
    ABI

  6. In vivo CAR T cell generation to treat cancer and autoimmune disease

    Theresa Hunter, Yanjie Bao, Yan Zhang +37

    Maqola20253 iqtibos
    ABI

  7. Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

    Wenqun Zhong, Zebin Xiao, Zhiyuan Qin +11

    MaqolaOchiq kirish20233 iqtibos
    ABI

  8. Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells

    Omkar U. Kawalekar, Roddy S. O’Connor, Joseph A. Fraietta +11

    MaqolaOchiq kirish20162 iqtibos
    ABI

  9. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

    Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando +34

    MaqolaOchiq kirish20182 iqtibos
    ABI

  10. Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

    Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus +9

    MaqolaOchiq kirish20132 iqtibos
    ABI

  11. Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells

    Sangya Agarwal, M. Ángela Aznar, Andrew J. Rech +17

    MaqolaOchiq kirish20232 iqtibos
    ABI

  12. Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

    Stephen Bagley, Meghan Logun, Joseph A. Fraietta +30

    MaqolaOchiq kirish20242 iqtibos
    ABI

  13. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

    Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons +35

    Maqola20182 iqtibos
    ABI

  14. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

    Melody Smith, Anqi Dai, Guido Ghilardi +46

    Maqola20222 iqtibos
    ABI